Sandoz News
-
13-05-2008 International presentation of clinical safety and efficacy data for Binocrit®, the world’s first complex biosimilar
- - First international presentation of clinical evidence supporting a biopharmaceutical approved by the biosimilar regulatory process
- - Data demonstrate safety and efficacy of Binocrit® in anemia treatment
- - Sandoz further confirms pioneering position in biosimilars, enhancing patient access to high-quality, affordable biopharmaceuticals
-
30-04-2008 Sandoz Receives Regulatory Guidance on Enoxaparin ANDA
Expects to Submit Amendment to ANDA in Third Quarter, 2008
...
Welcome to Sandoz
You have just entered the world of Sandoz - a healthy decision. Sandoz is a global leader in the rapidly growing generics industry, present in more than 130 countries. If you are interested in Sandoz International, you are already at the right place. To find out more about a specific country, just click on the worldwide map.
If you have any further questions, please contact us.



